申请人:Yao Wenqing
公开号:US08754114B2
公开(公告)日:2014-06-17
The present invention relates to substituted imidazopyridazines and substituted benzimidazoles, as well as pharmaceutical compositions comprising the same, which are FGFR3 inhibitors useful in the treatment of cancer and other diseases.
本发明涉及取代
咪唑吡啶和取代
苯并咪唑酮,以及包含它们的制药组合物,它们是FGFR3
抑制剂,可用于治疗癌症和其他疾病。